Danish Startup Light Leverages AI To Revolutionize Financial Automation

by THEFUTURE.TEAM

September 25, 2025

Harnessing AI: A New Era for Finance and Accounting

Danish startup Light is redefining the financial technology landscape by harnessing artificial intelligence to automate core functions within corporate finance departments. Founded in 2022 and headquartered in Copenhagen, the company is pioneering sophisticated software that streamlines accounting, bookkeeping, and financial reporting, challenging conventional systems long dominated by industry giants.

Strategic Funding Fuels Expansion

Light recently secured $30 million in a Series A funding round led by Balderton Capital, an early backer of fintech disruptors such as Revolut and GoCardless. The round also attracted significant investments from Atomico, Cherry Ventures, Seedcamp, Entrée Capital, and notable angel investors, including Hugging Face co-founder Thomas Wolf and Meta board member Charlie Songhurst. With these funds, CEO and co-founder Jonathan Sanders emphasized a strategic pivot towards accelerating commercial growth. The recent establishment of a London office, coupled with imminent plans to launch a New York branch, underscores Light’s commitment to capturing evolving global demand.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Challenging the Status Quo

As traditional enterprise systems provided by Microsoft, Oracle, and SAP continue to dominate the market, Light positions itself as a nimble alternative designed specifically for fast-growing companies. Sanders explained that many established platforms are often cumbersome, requiring prolonged adjustments to meet the dynamic needs of scaling businesses. For clients such as the innovative Swedish AI firm Lovable and Sana Labs, which is currently being acquired by Workday for $1.1 billion, Light’s automated solutions offer a streamlined approach that dramatically enhances operational efficiency.

Transformative Impact of AI in Finance

Sanders envisions a future where artificial intelligence fundamentally transforms financial operations. By converting expansive volumes of financial data and documentation into actionable insights, AI can eliminate the need for manual interventions that bog down traditional workflows. For example, tasks as mundane as verifying team meal allowances can be automated through an AI-driven agent accessing pertinent company policies—a process that would otherwise require hours of manual review.

Enterprise-Centric Vision

Looking ahead, Light is set to focus on large-scale enterprise clients facing challenges with outdated processes. As Sanders notes, no team can feasibly manage, reconcile, and update thousands of pages of policies without an intelligent, automated solution at their disposal. This strategic direction not only cements Light’s role as a disruptive force within the financial software industry but also underscores the broader narrative of digital transformation across traditional corporate sectors.

The Future Forbes Realty Global Properties

Blood Proteins May Signal Prostate Cancer Risk More Than 15 Years Before Diagnosis

by THEFUTURE.TEAM

October 27, 2026

Distinctive proteins in men’s blood may offer clues to prostate cancer risk more than 15 years before a diagnosis, according to research from the University of Oxford. The findings could help scientists better understand why some prostate cancers become aggressive while others grow slowly and never cause serious harm.

Researchers analyzed blood samples from 2,555 men collected between 1992 and 2000. Of those participants, 982 were later diagnosed with prostate cancer; the remaining 1,573 served as a comparison group. The team measured more than 6,000 proteins in the samples, which had been collected years—and, in some cases, more than 15 years—before diagnosis.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Protein Patterns Were Linked To Different Risks

The analysis identified proteins associated with prostate cancer risk overall, as well as proteins linked specifically to more aggressive or fast-growing forms of the disease. Higher levels of certain immune-system proteins, including GZMK and ANXA2, were associated with a lower long-term risk.

“Finding proteins linked to known prostate cancer driver genes in blood collected years before diagnosis gives us new insights into the earliest stages of the disease,” said Karl Smith-Byrne, the study’s corresponding author at Oxford.

The results, published in European Urology, are significant because prostate cancer is not a single, uniform disease. Many tumors grow slowly and may never threaten a patient’s health, while others progress rapidly and can be life-threatening. A clearer way to distinguish between these outcomes could eventually help improve how clinicians assess risk.

Promising Findings, Not A Screening Test

The researchers stressed that the protein patterns are not ready to be used as a screening test. The associations need further validation before they can inform clinical decisions, and the study does not establish that the proteins cause cancer or that measuring them can predict an individual’s outcome.

“Ultimately, we hope this will help us understand the biology of aggressive prostate cancer and identify markers that could improve how we assess risk in the future,” said first author Zhe Huang, a postdoctoral epidemiologist at Oxford Population Health.

Research Could Point To New Prevention Strategies

Prostate cancer is the most commonly diagnosed cancer among men in the European Union and the second most common worldwide, after lung cancer. In the EU, approximately 330,000 cases are diagnosed and 75,000 men die from the disease each year.

By identifying biological signals that appear long before diagnosis, the research may help scientists investigate the pathways involved in aggressive disease. Smith-Byrne said that, alongside existing and future genetic evidence, the findings could help reveal pathways that might ultimately be targeted to prevent aggressive prostate cancer.

Breaking news